XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, common stock (in shares) at Mar. 31, 2018     53,396,000          
Beginning balance, treasury stock (in shares) at Mar. 31, 2018         353,000      
Beginning balance at Mar. 31, 2018 $ 1,178,610 $ 1,343 $ 534 $ 468,783 $ (7,669) $ (19,315) $ 736,277 $ 1,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation $ 7,438     7,438        
Exercise of stock options (in shares) 97,700   98,000          
Exercise of stock options $ 2,931     2,931        
Issuance of shares related to restricted stock (in shares)     176,000          
Issuance of shares related to restricted stock     $ 2 (2)        
Treasury share repurchases (in shares)         1,518,000      
Treasury share repurchases (52,259)       $ (52,259)      
Net income (loss) (35,800)           (35,800)  
Other comprehensive income (loss) (6,432)         (6,432)    
Ending balance, common stock (in shares) at Mar. 31, 2019     53,670,000          
Ending balance, treasury stock (in shares) at Mar. 31, 2019         1,871,000      
Ending balance at Mar. 31, 2019 1,095,831   $ 536 479,150 $ (59,928) (25,747) 701,820  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation $ 7,644     7,644        
Exercise of stock options (in shares) 47,900   48,000          
Exercise of stock options $ 1,324   $ 1 1,323        
Issuance of shares related to restricted stock (in shares)     87,000          
Issuance of shares related to restricted stock 0   $ 1 (1)        
Treasury share repurchases (in shares)         1,848,000      
Treasury share repurchases (57,695)       $ (57,695)      
Net income (loss) 142,281           142,281  
Other comprehensive income (loss) $ (18,414)         (18,414)    
Ending balance, common stock (in shares) at Mar. 31, 2020     53,805,000          
Ending balance, treasury stock (in shares) at Mar. 31, 2020 3,719,000       3,719,000      
Ending balance at Mar. 31, 2020 $ 1,170,971   $ 538 488,116 $ (117,623) (44,161) 844,101  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation $ 8,543     8,543        
Exercise of stock options (in shares) 119,600   120,000          
Exercise of stock options $ 2,851   $ 1 2,850        
Issuance of shares related to restricted stock (in shares)     74,000          
Issuance of shares related to restricted stock 0   $ 1 (1)        
Treasury share repurchases (in shares)         369,000      
Treasury share repurchases (13,109)       $ (13,109)      
Net income (loss) 164,682           164,682  
Other comprehensive income (loss) $ 24,360         24,360    
Ending balance, common stock (in shares) at Mar. 31, 2021     53,999,000          
Ending balance, treasury stock (in shares) at Mar. 31, 2021 4,088,000       4,088,000      
Ending balance at Mar. 31, 2021 $ 1,358,298   $ 540 $ 499,508 $ (130,732) $ (19,801) $ 1,008,783